AG
EBS icon

Algert Global’s Emergent Biosolutions EBS Stock Holding History

Algert Global’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,520
Closed -$86K – 1181
2025
Q2 		$86K Buy
+13,520
New +$77.4K ﹤0.01% 1144
2022
Q4 		– Sell
-11,685
Closed -$245K – 1165
2022
Q3 		$245K Buy
+11,685
New +$325K 0.01% 998

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Algert Global's EBS Position: Q3 2025 in Review

Algert Global sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 13,520 shares — an estimated $86K sold.

Algert Global first reported a position in EBS in Q3 2022 and held it in 2 quarters. The position peaked at $245K in Q3 2022. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • Algert Global reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • Algert Global sold 13,520 Emergent Biosolutions shares in Q3 2025, an estimated $86K.
  • Algert Global first reported a position in Emergent Biosolutions in Q3 2022 and held it in 2 quarters.
  • Algert Global's Emergent Biosolutions position peaked at $245K in Q3 2022.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Algert Global's 13F filing for Q3 2025, filed 14 Nov 2025.